The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations

被引：24

作者：

Fryzek J.P. ^{[1
,3
]}

Garabrant D.H. ^{[1
,2
]}

Schenk M. ^{[4
,5
]}

Kinnard M. ^{[6
]}

Greenson J.K. ^{[7
]}

Sarkar F.H. ^{[8
]}

机构：

[1] Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI 48109-2029

[2] Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109-2029

[3] Department of Epidemiology, Amgen Inc., MS:24-2-A, Thousand Oaks, CA 91320, One Amgen Center Drive

[4] Karmanos Cancer Institute, Epidemiology Section, Detroit, MI 48201

[5] Department of Family Medicine, Wayne State University, UHC-4J, Detroit, MI 48201

[6] Division of Gastroenterology, Department of Medicine, Case Western University School of Medicine, Cleveland, OH

[7] Department of Pathology, University of Michigan School of Medicine, Ann Arbor

[8] Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201

来源：

Journal of Gastrointestinal Cancer | 2006年 / 37卷 / 4期

关键词：

Epidemiology; K-ras codon 12 mutations; p53; mutations; Pancreatic cancer; Risk factors;

D O I：

10.1007/s12029-007-9005-8

中图分类号：

学科分类号：

摘要：

Background: Pancreatic cancer is a major contributor to cancer mortality. Studies suggest that a few risk factors, including cigarette smoking, body mass index, having a relative with pancreatic cancer, and diabetes may be related to pancreatic cancer risk. Aim of the Study: We conducted a case-control study in southeastern Michigan to examine the relation between the abovementioned risk factors and mutations of the K-ras oncogene and p53 tumor suppressor gene. Methods: Two hundred forty-five patients with newly diagnosed pancreatic cancer and 420 general population controls were enrolled in the study. For this analysis, all case subjects were restricted to the pancreatic cancer patients that had tissue blocks available for study (n = 51). In-person interviews were conducted to ascertain information on demographic and lifestyle factors. Adjusted logistic regression analyses were conducted to compare various subject characteristics of pancreatic cancer patients with K-ras and p53 mutations and their subtypes to the characteristics of the general population controls. Results: Smoking (adjusted odds ratio [aOR] = 2.0; 95% confidence interval [95%CI] = 0.9-4.3) and diabetes diagnosed 5 or more years before interview (aOR = 3.4; 95%CI = 1.3-8.8) were associated with pancreatic cancer patients positive for K-ras codon 12 mutations, but not with pancreatic cancer patients negative for K-ras codon 12 mutations. On the other hand, none of the examined risk factors were meaningfully related to patients with p53 mutations. Conclusions: This study suggests that some recognized risk factors for pancreatic cancer may also be associated with K-ras codon 12 mutations. However, further large-scale studies are warranted. © 2007 Humana Press Inc.

引用

页码：139 / 145

页数：6

共 22 条

[1]

Cancer Facts & Figures 2006, (2006)

[2]

Lowenfels A.B., Maisonneuve P., Epidemiology and risk factors for pancreatic cancer, Best Pract Res Clin Gastroenterol, 20, pp. 197-209, (2006)

[3]

Schenk M., Schwartz A.G., O'Neal E., Kinnard M., Greenson J.K., Fryzek J.P., Et al., Familial risk of pancreatic cancer, J Natl Cancer Inst, 93, pp. 640-644, (2001)

[4]

Fryzek J.P., Schenk M., Kinnard M., Greenson J.K., Garabrant D.H., The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999, Am J Epidemiol, 162, pp. 222-228, (2005)

[5]

Moore P.S., Beghelli S., Zamboni G., Scarpa A., Genetic abnormalities in pancreatic cancer, Mol Cancer, 2, (2003)

[6]

Hruban R.H., Van Mansfeld A.D.M., Offerhaus G.J.A., Van Weering D.H.J., Allison D.C., Goodman S.N., Et al., K-ras oncogene activation in adenocarcinoma of the human pancreas, Am J Pathol, 143, pp. 545-554, (1993)

[7]

Lepkowski J.M., Groves R., Telephone sampling methods in the United States, Telephone Survey Methodology, pp. 73-98, (1998)

[8]

Sarkar F.H., Valdivieso M., Borders J., Yao K.L., Raval M.M., Madan S.K., Et al., A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue, Diagn Mol Pathol, 4, pp. 266-273, (1995)

[9]

Palesty J.A., Dudrick S.J., What we have learned about cachexia in gastrointestinal cancer, Dig Dis, 21, pp. 198-213, (2003)

[10]

Moodie S.A., Willumsen B.M., Weber M.J., Woolfman A., Complexes of ras-gtp with Raf-1 and mitogen-activated protein kinase kinase, Science, 260, pp. 1658-1661, (1993)

← 1 2 3 →